A
Aspen Pharmacare Holdings Ltd
OTC:APNHY
Aspen Pharmacare Holdings Ltd
OTC:APNHY
Price:
7.63
USD
2.01%
Market Closed
Market Cap:
$3.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Aspen Pharmacare Holdings Ltd
OTC:APNHY
|
ZA |
|
A
|
Anhui Genuine New Materials Co Ltd
SSE:603429
|
CN |
|
Denny's Corp
NASDAQ:DENN
|
US |
|
Macquarie Group Ltd
ASX:MQG
|
AU |
|
Mayora Indah Tbk PT
IDX:MYOR
|
ID |
|
M
|
Metalo Manufacturing Inc
CNSX:MMI
|
CA |
|
Silver X Mining Corp
XTSX:AGX
|
CA |
|
Danone SA
PAR:BN
|
FR |
|
D
|
Dragon Crown Group Holdings Ltd
HKEX:935
|
HK |
|
Biotest AG
XETRA:BIO
|
DE |
|
SOCAM Development Ltd
HKEX:983
|
HK |
|
Jinjian Cereals Industry Co Ltd
SSE:600127
|
CN |
|
Joey New York Inc
OTC:JOEY
|
US |
|
Y
|
Y Optics Manufacture Co Ltd
KOSDAQ:066430
|
KR |
|
A
|
American CuMo Mining Corp
XTSX:MLY
|
CA |
|
Noratis AG
XETRA:NUVA
|
DE |
|
D
|
Drax Group PLC
F:D9F2
|
UK |
|
Regions Financial Corp
NYSE:RF
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of APNHY.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
APNHY
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
APNHY Competitors Multiples
Aspen Pharmacare Holdings Ltd Competitors
Aspen Pharmacare Holdings Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| ZA |
A
|
Aspen Pharmacare Holdings Ltd
OTC:APNHY
|
57.8B USD | 1.5 | -28.9 | -127.6 | -127.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 9.8 | 7.3 | 8.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
